OpenEvidence
Medical information and clinical decision-support company providing an AI platform that synthesizes peer-reviewed research, guidelines and licensed medical content for clinicians.
$15B*25.0%increase
| Name | Type | Category | Launched | Latest release | Status |
|---|---|---|---|---|---|
| OpenEvidence Global | Product | Global Health | Sep 2026 | OpenEvidence begins global localized rollout | rolling out |
| OpenEvidence | Platform | Medical Information Platform | Jan 2023 | OpenEvidence launches medical information platform | active |
* Market cap / valuation. Company values are AI-attributed: the latest market cap or valuation × the share attributed to AI (100% for pure AI companies). Methodology